Diversify Advisory Services, LLC Ascendis Pharma A/S Transaction History
Diversify Advisory Services, LLC
- $1.6 Trillion
- Q1 2025
A detailed history of Diversify Advisory Services, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Diversify Advisory Services, LLC holds 1,991 shares of ASND stock, worth $339,943. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,991Holding current value
$339,943% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
242Shares Held
59.5MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.73 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$944 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$871 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$760 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$748 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.53B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...